After 5,000 Deaths from Ebola and COVID, Liberia Faces New Mpox Threat

In the decade that has defined Liberia’s modern public health trajectory, the collective memory of the nation remains etched with the trauma of two catastrophic events: the West African Ebola epidemic of 2014-2016 and the global COVID-19 pandemic. Together, these crises claimed over 5,000 Liberian lives, shuttering businesses, overwhelming fragile infrastructure, and forcing a national reckoning with the country’s health security apparatus. Today, that memory is being tested once more as Liberia finds itself in the grip of a surging Mpox threat. With four new cases confirmed across Montserrado, Margibi, and Sinoe counties, the National Public Health Institute of Liberia (NPHIL) and the Ministry of Health are scrambling to contain an outbreak that has already logged 78 confirmed cases and 652 suspected infections since the beginning of 2024.

While government officials maintain a veneer of control, for many observers and long-suffering citizens, the situation feels uncomfortably familiar: a reactive, delayed response that risks evolving into a preventable tragedy. At the center of the current strategy is Dr. Dougbeh Chris Nyan, the Director-General of NPHIL, who recently held a press briefing in Congo Town to project confidence. Dr.

Nyan, a respected figure in the scientific community, urged the public to eschew panic and adhere to rigorous health protocols. He has leaned heavily on the ‘717 Procedure’—a strategy for rapid case identification, reporting, and management within 7, 1, and 7 days—which has garnered praise from the Africa CDC. Yet, as the numbers continue to climb, the disconnect between institutional technical prowess and the realities on the ground has become a focal point of public scrutiny. The core of the critique lies not in the scientific capabilities of NPHIL, but in the operational speed and the depth of government commitment.

Despite receiving a donation of over 10,000 doses of the Mpox vaccine from the Africa CDC, the rollout has been agonizingly slow. Reports indicate that only about 2,000 high-risk individuals have been inoculated to date, primarily concentrated in counties like Grand Cape Mount, Nimba, Grand Bassa, and Sinoe. Crucially, the vaccine has yet to reach the most critical hub: Montserrado County. As home to the capital city, Monrovia, and the densest concentration of people in the country, Montserrado is the most fertile ground for rapid viral transmission.

The delay in initiating vaccination campaigns there reflects a systemic inability to prioritize population density when allocating medical resources. The current strategy, which limits vaccination to frontline health workers and the immediate close contacts of confirmed cases, is being described by many public health analysts as a containment measure that ignores the potential for widespread community transmission. When vaccination is restricted to such a narrow window of eligibility, the virus is effectively allowed to move through the population unchecked. This is not merely an administrative oversight; it is a manifestation of a deeper, long-standing issue in Liberia’s political economy.

For years, international partners have poured resources into establishing NPHIL as a regional Center of Excellence. However, external assessments from the Africa CDC and other international bodies have repeatedly flagged chronic administrative hurdles: bureaucratic delays in procurement, insufficient domestic funding to supplement donor aid, and an enduring struggle to translate leadership rhetoric into measurable field outcomes. The fragility of this system is laid bare by its near-total reliance on donor-funded equipment and technical guidance. When the global attention on a specific outbreak wanes, or when international logistical chains are disrupted, Liberia’s capacity to pivot independently becomes severely compromised.

This reliance creates a dangerous cycle of dependency. History offers a sobering lesson. In 2014, the initial response to Ebola was marred by denial and a profound lack of community trust. It took the horrific loss of thousands of lives before the government could successfully mobilize a coordinated national response.

The COVID-19 pandemic brought similar challenges, as vaccine hesitancy and misinformation complicated the deployment of life-saving measures. Today, the skepticism surrounding the Mpox response is not a result of ignorance, but a learned behavior born from these past failures. When citizens see that vaccines are available but sitting in cold storage while the virus circulates, the legitimacy of the Ministry of Health is eroded. Public trust is the most critical currency in a public health crisis; without it, even the most advanced scientific protocols will fail to change the behaviors necessary to break the chains of transmission.

The social and economic implications of an unchecked Mpox outbreak cannot be overstated. Liberia’s economy, already struggling with high inflation and limited fiscal space, is highly sensitive to health shocks. A major outbreak would threaten not only the health of the workforce but also the stability of the informal markets upon which most Liberians rely for their daily survival. The history of the Ebola crisis showed that when fear takes hold, trade slows, school attendance drops, and household incomes evaporate.

Preventing this scenario requires more than just press briefings and optimistic data reports; it requires a genuine commitment to transparency. The Liberian public is demanding clear, consistent messaging regarding why the vaccine rollout has been delayed in Montserrado and what steps are being taken to ensure that health centers across all 15 counties are properly equipped to handle both diagnosis and treatment. Accountability in the health sector is no longer an optional luxury; it is a national security imperative. The regional significance of this situation is also paramount.

As a member of the Mano River Union, Liberia’s health outcomes are inextricably linked to those of Sierra Leone, Guinea, and Côte d’Ivoire. An unchecked outbreak in the capital of Monrovia carries with it the risk of cross-border transmission, potentially destabilizing a sub-region that has worked hard to recover from decades of conflict and health crises. The Africa CDC is looking for success stories in its partner nations; Liberia has the potential to lead, but it must move past the reactive posture that has defined its recent history. The path forward is clear.

First, the government must accelerate the deployment of the remaining 8,000 vaccine doses to the urban centers where the population is most vulnerable. Second, it must engage in a more robust and sincere communication strategy that acknowledges the gaps in the system while outlining a clear, time-bound plan for improvement. Finally, it is time for a broader, honest conversation about the sustainability of the national health budget. Relying solely on the generosity of international donors to fill gaps in cold-chain logistics and frontline deployment is a stop-gap measure, not a policy.

If Liberia is to finally break the cycle of preventable health tragedies, the government must treat public health with the same urgency as any other national security issue. The people of Liberia deserve a health system that anticipates threats rather than merely documenting their toll. As the confirmed cases grow and the specter of the past looms large, the administration has a narrow window of opportunity to pivot from reactive management to proactive protection. The lives of thousands, and the stability of the nation, depend on it.